30-Day Appeals Period
Once the CSAC’s decisions are made public via the PQM website, a 30-day appeals period begins. Any interested party may file an appeal with the Appeals Board during the appeals period.
Fall 2022
Alignment of Person Centered Service Plan (PCSP) with Functional Assessment Standardized items (FASI) needs
-
The percentage of home and community-based services (HCBS) recipients aged 18 years or older whose PCSP documentation addresses needs in the areas of self-care, mobility, and instrumental activities of daily living (IADL) as determined by the most recent FASI assessment. For the purposes of this measure application, the term home and community-based services also will refer to community-based long-term services and supports (CB-LTSS).CBE ID3734
CDC, National Healthcare Safety Network (NHSN) Hospital-Onset Bacteremia & Fungemia Outcome Measure
-
Risk-adjusted ratio of observed bacteremias and fungemias to predicted bacteremias and fungemias among patients previously admitted to acute care hospitals.CBE ID3686
CDC, NHSN Healthcare Facility Onset, Antibiotic Treated Clostridiodes Difficile Infection Outcome Measure
-
Standardized infection ratio (SIR) based on fully electronic capture of healthcare facility-onset, antibiotic-Treated Clostridioides difficile Infection (HT-CDI) events among inpatients in the facilityCBE ID3688
CSAC Endorsement Meeting
The Consensus Standards Approval Committee (CSAC) will be convened to endorse or decline to endorse candidate measures for the Fall 2022 cycle. The CSAC makes endorsement decisions about candidate measures that have been reviewed by project committees, following the public comment period.
CSAC Endorsement Meeting (Backup Date)
The Consensus Standards Approval Committee (CSAC) will be convened to endorse or decline to endorse candidate measures for the Fall 2022 cycle. The CSAC makes endorsement decisions about candidate measures that have been reviewed by project committees, following the public comment period.
CVD Risk Assessment Measure – Proportion of Pregnant/Postpartum Patients That Receive CVD Risk Assessment with a Standardized Tool
-
The University of California, Irvine (UCI) implemented and tested a CVD risk assessment algorithm that can be integrated into the electronic health record (EHR) system that immediately identifies patients who are at increased risk for CVD. The unit of measurement is individual patients, and the population will include any patient who has a prenatal or postpartum visit in the hospital system. This includes pregnant and postpartum emancipated minors.CBE ID3716
CVD Risk Follow-up Measure - Proportion of patients with a positive CVD risk assessment who receive follow-up care
-
All pregnant and postpartum patients need to be systematically assessed for cardiovascular disease (CVD). Once identified as being at risk for CVD follow-up cardiac tests and consultations are scheduled. UCI implemented and tested a standardized CVD risk assessment algorithm that can be integrated into the EHR system and provides an immediate triage of patients as low and high risk for CVD.CBE ID3735